Zymeworks (NYSE:ZYME) reported Q1 EPS of ($1.19), $0.48 better than the analyst estimate of ($1.67). Revenue for the quarter came in at $1.9 million versus the consensus estimate of $3.47 million.
Zymeworks (NYSE:ZYME) reported Q1 EPS of ($1.19), $0.48 better than the analyst estimate of ($1.67). Revenue for the quarter came in at $1.9 million versus the consensus estimate of $3.47 million.